Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial.
暂无分享，去创建一个
T. Ciuleanu | B. Alekseev | S. Pal | D. Castellano | K. Sunela | S. Rha | D. Heng | P. Koralewski | D. Stroyakovskiy | Alan D. Smith | F. Parnis | J. Puente | H. Glen | J. Lee | K. O’Hara | T. Binder | Lixian Peng | K. O'hara